Haemonetics Corporation  

(Public, NYSE:HAE)   Watch this stock  
Find more results for Susan White�
37.89
-0.07 (-0.18%)
Real-time:   10:24AM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 37.68 - 38.20
52 week 29.86 - 43.60
Open 38.20
Vol / Avg. 22,130.00/239,070.00
Mkt cap 1.95B
P/E 65.61
Div/yield     -
EPS 0.58
Shares 51.34M
Beta 0.72
Inst. own 104%
Jan 26, 2015
Q3 2015 Haemonetics Corp Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 20, 2014
Haemonetics Corp at Jefferies Global Healthcare Conference - London
Nov 3, 2014
Q2 2015 Haemonetics Corp Earnings Release
Nov 3, 2014
Q2 2015 Haemonetics Corp Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 3.29% 3.75%
Operating margin 5.45% 5.04%
EBITD margin - 13.93%
Return on average assets 2.04% 2.36%
Return on average equity 3.67% 4.37%
Employees 3,782 -
CDP Score - -

Address

400 WOOD RD
BRAINTREE, MA 02184
United States - Map
+1-781-8487100 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Haemonetics Corporation is a healthcare company engaged in providing blood management solutions to its customers. The Company�s portfolio of integrated devices, information management and consulting services offers blood management solutions for each facet of the blood supply chain, helping improve clinical outcomes and reduce costs for blood and plasma collectors, hospitals, and patients around the world.The Company serves three markets: manufacturers of plasma derived pharmaceuticals, blood collectors and hospitals. Plasma includes plasma collection devices and consumables. Blood Center includes blood collection and processing devices and consumables. Hospital includes surgical blood salvage and blood demand diagnostic devices and consumables. Software Solutions includes information technology platforms and consulting services provided to all three markets. On April 30, 2013, the Company acquired of certain assets of Hemerus LLC.

Officers and directors

Brian P. Concannon President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Christopher J. Lindop Chief Financial Officer, Executive Vice President - Business Development
Age: 56
Bio & Compensation  - Reuters
Peter M. Allen President - Global Plasma
Age: 55
Bio & Compensation  - Reuters
David D. Helsel Executive Vice President - Global Manufacturing
Age: 50
Bio & Compensation  - Reuters
Jonathan White Chief Science and Technology Officer
Age: 54
Bio & Compensation  - Reuters
Susan Hanlon Chief Accounting Officer, Vice President - Finance
Age: 46
Bio & Compensation  - Reuters
Sandra Jesse Vice President, Chief Legal Officer
Age: 61
Bio & Compensation  - Reuters
Richard J. Meelia Non-Executive Independent Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Susan Bartlett Foote Independent Director
Age: 67
Bio & Compensation  - Reuters
Ronald G. Gelbman Independent Director
Age: 66
Bio & Compensation  - Reuters